Evidence map›Paper›PMID 41978732›Full record

ArticleVirus evolution2026

Identification and genomic characterization of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa.

Graeme Dor, Dikeledi Kekana, Ryan Hisner, Darren P Martin, Bette Korber, Timo Ernst, Avram Levy, David Speers, Stuart Turville, Vitali Sintchenko and 12 more

Abstract read
In one paragraph

Article in Virus evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Graeme DorCentre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Van der Byl Road, Stellenbosch Central, Stellenbosch, Western Cape, 7600, South Africa.ORCID https://orcid.org/0000-0001-9036-9933
Dikeledi KekanaCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD), A Division of the National Health Laboratory Service (NHLS), 1 Modderfontein Road, Sandringham, Johannesburg, Gauteng, 2192, South Africa.
Ryan HisnerDivision of Computational Biology, Department of Integrative Biomedical Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Anzio Road, Observatory, Cape Town, Western Cape, 7925, South Africa.
Darren P MartinDivision of Computational Biology, Department of Integrative Biomedical Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Anzio Road, Observatory, Cape Town, Western Cape, 7925, South Africa.ORCID https://orcid.org/0000-0002-8785-0870
Bette KorberTheoretical Biology and Biophysics, Los Alamos National Laboratory, Bikini Atoll Road, Los Alamos, NM 87545, United States.
Timo ErnstPathWest Laboratory Medicine WA, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, Perth, Western Australia, WA 6150, Australia.ORCID https://orcid.org/0000-0001-8834-6812
Avram LevyPathWest Laboratory Medicine WA, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, Perth, Western Australia, WA 6150, Australia.ORCID https://orcid.org/0000-0002-0934-2387
David SpeersPathWest Laboratory Medicine WA, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, Perth, Western Australia, WA 6150, Australia.ORCID https://orcid.org/0009-0003-0249-5780
Stuart TurvilleThe Kirby Institute, University of New South Wales, Wallace Wurth Building, High Street, Kensington, Sydney, New South Wales, NSW 2052, Australia.
Vitali SintchenkoCentre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology - Institute of Clinical Pathology and Medical Research (ICPMR), Centre for Infectious Diseases and Microbiology - Public Health, University of Sydney, Westmead Hospital, Darcy Road, Westmead, Sydney, New South Wales, NSW 2145, Australia.ORCID https://orcid.org/0000-0002-9261-3650
Kerri BasileCentre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology - Institute of Clinical Pathology and Medical Research (ICPMR), Centre for Infectious Diseases and Microbiology - Public Health, University of Sydney, Westmead Hospital, Darcy Road, Westmead, Sydney, New South Wales, NSW 2145, Australia.ORCID https://orcid.org/0000-0003-0647-4314
Geraldine SullivanCentre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology - Institute of Clinical Pathology and Medical Research (ICPMR), Centre for Infectious Diseases and Microbiology - Public Health, University of Sydney, Westmead Hospital, Darcy Road, Westmead, Sydney, New South Wales, NSW 2145, Australia.ORCID https://orcid.org/0000-0001-5253-8660
Rebecca RockettCentre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology - Institute of Clinical Pathology and Medical Research (ICPMR), Centre for Infectious Diseases and Microbiology - Public Health, University of Sydney, Westmead Hospital, Darcy Road, Westmead, Sydney, New South Wales, NSW 2145, Australia.ORCID https://orcid.org/0000-0003-4329-5198
Jen KokCentre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology - Institute of Clinical Pathology and Medical Research (ICPMR), Centre for Infectious Diseases and Microbiology - Public Health, University of Sydney, Westmead Hospital, Darcy Road, Westmead, Sydney, New South Wales, NSW 2145, Australia.ORCID https://orcid.org/0000-0002-8796-283X
Josette SchoenmakersIndependent Researcher, Haarlem, North Holland, 2011, the Netherlands.
Federico GueliIndependent Researcher, Como, Lombardy, 22100, Italy.
Richard LesselsKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Medicine, University of KwaZulu-Natal, 719 Umbilo Road, Congella, Durban, KwaZulu-Natal, 4001, South Africa.
Cheryl BaxterCentre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Van der Byl Road, Stellenbosch Central, Stellenbosch, Western Cape, 7600, South Africa.
Nicole WolterCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD), A Division of the National Health Laboratory Service (NHLS), 1 Modderfontein Road, Sandringham, Johannesburg, Gauteng, 2192, South Africa.ORCID https://orcid.org/0000-0002-9526-0133
Anne von GottbergCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD), A Division of the National Health Laboratory Service (NHLS), 1 Modderfontein Road, Sandringham, Johannesburg, Gauteng, 2192, South Africa.ORCID https://orcid.org/0000-0002-0243-7455
Houriiyah TegallyCentre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Van der Byl Road, Stellenbosch Central, Stellenbosch, Western Cape, 7600, South Africa.
Tulio de OliveiraCentre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Van der Byl Road, Stellenbosch Central, Stellenbosch, Western Cape, 7600, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In November 2024, a highly divergent BA.3-related severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage, designated BA.3.2, was detected in South Africa, marking the first appearance of a BA.3-derived lineage in over 2 years. Phylogenetic reconstruction places BA.3.2 on an extended branch descending from ancestral BA.3, with no intermediate genomes detected, consistent with a prolonged period of unsampled or isolated evolution. Molecular clock analyses indicate accelerated divergence characteristic of a saltation event, whilst phylogeographic and demographic analyses point to a southern African origin followed by multiple independent exportations and evidence of ongoing global transmission. Relative to ancestral BA.3, BA.3.2 harbours 39 amino acid substitutions in the spike glycoprotein, two N-terminal domain deletions (Δ136-147 and Δ243-244), a four-residue insertion (ins214:ASDT), and a large deletion spanning ORF7a, ORF7b, and ORF8. The co-occurrence of D405N and R408S implies epistasis between these sites, whilst reversions R493Q and H505Y likely enhance ACE2 binding and antibody escape. Extensive remodelling across the spike, including loss of the C15-C136 disulphide bond and substitutions in the SD1 and SD2 domains, may influence spike stability, cleavage, and fusogenicity. The emergence and continued circulation of BA.3.2 underscores the ongoing potential for highly divergent SARS-CoV-2 variants to arise and spread globally. Despite its limited prevalence, the persistence of BA.3.2 alongside dominant lineages, together with evidence of more recent expansion, indicate that this lineage retains the potential to become of epidemiological concern under favourable conditions.

Indexed as

BA.3.2omicronphylogeneticsSARS-CoV-2viral evolution

Identifiers

PMID41978732
PMCPMC13070381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.